CrossRoads Extremity Systems, which J&J acquired in 2022, submitted the 510(k) filing for the TriLEAP plating system earlier this year. The device is designed to accommodate multiple screw diameters and features procedure-specific plate options.
The ORi device is intended to support standard pulse oximetry by providing additional insights into patients with higher than normal oxygenation.
Proprio today announced the successful first-in-human use of its Paradigm surgical technology platform for 3D visualization.
DePuy Synthes, the orthopedic device business of Johnson & Johnson (NYSE: JNJ)+
, has won FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system.
New research finds RNA-guided enzymes called Fanzors are widespread among eukaryotic organisms.
Orthofix today announced it received FDA 510(k) clearance for its OsteoCove bioactive synthetic graft.
The expanded indication positions Boston Scientific to challenge Abbott, Medtronic and Nevro for the emerging opportunity in spinal cord stimulation to treat the condition.
Medtronic (NYSE:MDT) announced that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system